BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32451927)

  • 1. Positive interaction of mangiferin with selected oral hypoglycemic drugs: a therapeutic strategy to alleviate diabetic nephropathy in experimental rats.
    Sekar V; Mani S; Malarvizhi R; Barathidasan R; Vasanthi HR
    Mol Biol Rep; 2020 Jun; 47(6):4465-4475. PubMed ID: 32451927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide.
    Sekar V; Mani S; Malarvizhi R; Nithya P; Vasanthi HR
    Phytomedicine; 2019 Jun; 59():152901. PubMed ID: 30981189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
    Maheshwari RA; Balaraman R; Sen AK; Seth AK
    Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats.
    Pal PB; Sinha K; Sil PC
    PLoS One; 2014; 9(9):e107220. PubMed ID: 25233093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
    Mulay SR; Gaikwad AB; Tikoo K
    Chem Biol Interact; 2010 Apr; 185(2):137-42. PubMed ID: 20223228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
    Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
    Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
    Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway.
    Song Y; Liu W; Tang K; Zang J; Li D; Gao H
    J Diabetes Res; 2020; 2020():9481720. PubMed ID: 32076626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms.
    Abd El Motteleb DM; Abd El Aleem DI
    Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):509-521. PubMed ID: 28079268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
    Liu YW; Zhu X; Zhang L; Lu Q; Wang JY; Zhang F; Guo H; Yin JL; Yin XX
    Eur J Pharmacol; 2013 Dec; 721(1-3):355-64. PubMed ID: 24036348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secoisolariciresinol diglucoside in high-fat diet and streptozotocin-induced diabetic nephropathy in rats: a possible renoprotective effect.
    Sherif IO
    J Physiol Biochem; 2014 Dec; 70(4):961-9. PubMed ID: 25316298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cissus quadrangularis extract attenuates diabetic nephropathy by altering SIRT1/DNMT1 axis.
    Syed AA; Reza MI; Garg R; Goand UK; Gayen JR
    J Pharm Pharmacol; 2021 Oct; 73(11):1442-1450. PubMed ID: 34128987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
    Hofni A; El-Moselhy MA; Taye A; Khalifa MM
    Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganoderma lucidum ameliorates the diabetic nephropathy via down-regulatory effect on TGFβ-1 and TLR-4/NFκB signalling pathways.
    Hassan HM; Mahran YF; Ghanim AMH
    J Pharm Pharmacol; 2021 Aug; 73(9):1250-1261. PubMed ID: 33847358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of HuoxueJiangtang decoction alone or in combination with metformin on renal function and renal cortical mRNA expression in diabetic nephropathy rats.
    Liu X; Liu D; Shuai Y; Li H; Zhao H; Qu X; Chu S; Zhang X
    Pharm Biol; 2020 Dec; 58(1):1123-1130. PubMed ID: 33191822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet.
    Onozato ML; Tojo A; Goto A; Fujita T
    Kidney Int; 2004 Mar; 65(3):951-60. PubMed ID: 14871415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model.
    Qiao L; Liu Y; Li C; Ge J; Li T
    Pharmacology; 2019; 104(5-6):258-266. PubMed ID: 31344701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy.
    Dugbartey GJ; Alornyo KK; N'guessan BB; Atule S; Mensah SD; Adjei S
    Biomed Pharmacother; 2022 May; 149():112818. PubMed ID: 35286963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.